FI841508A - Delbar tablett med foerdroejd frigivning av aktivaemne och foerfarande foer dess framstaellning. - Google Patents

Delbar tablett med foerdroejd frigivning av aktivaemne och foerfarande foer dess framstaellning. Download PDF

Info

Publication number
FI841508A
FI841508A FI841508A FI841508A FI841508A FI 841508 A FI841508 A FI 841508A FI 841508 A FI841508 A FI 841508A FI 841508 A FI841508 A FI 841508A FI 841508 A FI841508 A FI 841508A
Authority
FI
Finland
Prior art keywords
frigivning
foerdroejd
delbar
aktivaemne
tablett
Prior art date
Application number
FI841508A
Other languages
English (en)
Other versions
FI80590C (fi
FI841508A0 (fi
FI80590B (fi
Inventor
Bernd Zierenberg
Arun Rajaram Gupte
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6196696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI841508(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI841508A0 publication Critical patent/FI841508A0/fi
Publication of FI841508A publication Critical patent/FI841508A/fi
Application granted granted Critical
Publication of FI80590B publication Critical patent/FI80590B/fi
Publication of FI80590C publication Critical patent/FI80590C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
FI841508A 1983-04-18 1984-04-16 Foerfarande foer framstaellning av retarderat laekemedel frigoerande polyakrylbaserad deltablett. FI80590C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833314003 DE3314003A1 (de) 1983-04-18 1983-04-18 Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
DE3314003 1983-04-18

Publications (4)

Publication Number Publication Date
FI841508A0 FI841508A0 (fi) 1984-04-16
FI841508A true FI841508A (fi) 1984-10-19
FI80590B FI80590B (fi) 1990-03-30
FI80590C FI80590C (fi) 1990-07-10

Family

ID=6196696

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841508A FI80590C (fi) 1983-04-18 1984-04-16 Foerfarande foer framstaellning av retarderat laekemedel frigoerande polyakrylbaserad deltablett.

Country Status (27)

Country Link
US (3) US4547359A (fi)
EP (1) EP0122574B2 (fi)
JP (1) JPH0623096B2 (fi)
KR (1) KR910001924B1 (fi)
AT (1) ATE23110T1 (fi)
AU (1) AU575045B2 (fi)
CA (1) CA1232202A (fi)
CS (1) CS247079B2 (fi)
DD (1) DD223063A5 (fi)
DE (2) DE3314003A1 (fi)
DK (1) DK161183C (fi)
ES (1) ES8504453A1 (fi)
FI (1) FI80590C (fi)
GB (1) GB2138290B (fi)
GR (1) GR79858B (fi)
HK (1) HK1690A (fi)
HU (1) HU191558B (fi)
IE (1) IE57141B1 (fi)
IL (1) IL71558A (fi)
NO (1) NO164957C (fi)
NZ (1) NZ207876A (fi)
PH (1) PH19612A (fi)
PL (1) PL144291B1 (fi)
PT (1) PT78434B (fi)
SG (1) SG68889G (fi)
SU (1) SU1356951A3 (fi)
ZA (1) ZA842815B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3525767A1 (de) * 1985-07-19 1987-01-22 Boehringer Ingelheim Kg Pharmazeutische zubereitung mit kontrollierter und verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0359746B1 (en) * 1987-03-25 1992-06-03 E.I. Du Pont De Nemours And Company Use of vinyl alcohol homopolymers and copolymers for tableting active materials
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US5445830A (en) * 1989-07-25 1995-08-29 Otsuka Pharmaceutical Co., Ltd. Highly absorbable pharmaceutical composition
DE4029591C2 (de) * 1990-09-19 1995-01-26 Stockhausen Chem Fab Gmbh Verfahren zur Herstellung von Absorptionsmaterial auf Polymerbasis mit Zusatz von wasserlöslichen Substanzen und Verwendung dieses Absorptionsmaterials zur Aufnahme und/oder zur nachfolgenden Abgabe von Wasser oder wäßrigen Lösungen
DE4032096C2 (de) * 1990-10-10 1995-03-30 Boehringer Ingelheim Kg Verwendung emulgatorfreier Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6699963B2 (en) 2002-03-18 2004-03-02 The Procter & Gamble Company Grinding process for plastic material and compositions therefrom
US6770099B2 (en) 2002-11-19 2004-08-03 Zimmer Technology, Inc. Femoral prosthesis
BRPI0615860B8 (pt) * 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
WO2007138606A2 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB768291A (en) * 1953-12-16 1957-02-13 Schering Corp Pharmaceutical tablets
BE575343A (fi) * 1955-09-09
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
BE632692A (fi) * 1963-05-28
CH468192A (de) * 1964-06-19 1969-02-15 Ciba Geigy Verfahren zur Herstellung von Arzneimitteln in Perlenform
AT270071B (de) * 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
CH582002A5 (fi) * 1972-06-09 1976-11-30 Purdue Research Foundation
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
US4248855A (en) * 1976-08-27 1981-02-03 Hydrophilics International, Inc. Pharmaceutical base salts
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
US4152414A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
US4152415A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Method of increasing the effectiveness of oral vaccination for swine dysentery
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
ATE13486T1 (de) * 1980-11-12 1985-06-15 Ciba Geigy Ag Schnellzerfallende arzneimittel-presslinge.
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
GB2119648A (en) * 1982-05-06 1983-11-23 Joseph Hodgson Briggs Anorexogenic pharmaceutical composition
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung

Also Published As

Publication number Publication date
AU575045B2 (en) 1988-07-21
ES531684A0 (es) 1985-04-16
FI80590C (fi) 1990-07-10
US4683131A (en) 1987-07-28
GB2138290B (en) 1986-10-29
DK161183C (da) 1991-11-25
EP0122574A1 (de) 1984-10-24
EP0122574B2 (de) 1990-10-10
AU2701184A (en) 1984-10-25
NO164957C (no) 1990-12-05
SG68889G (en) 1990-01-26
DK119084D0 (da) 1984-02-28
GB8410010D0 (en) 1984-05-31
ATE23110T1 (de) 1986-11-15
GR79858B (fi) 1984-10-31
ZA842815B (en) 1985-12-24
ES8504453A1 (es) 1985-04-16
US4547359A (en) 1985-10-15
KR910001924B1 (ko) 1991-03-30
FI841508A0 (fi) 1984-04-16
PT78434A (de) 1984-05-01
HU191558B (en) 1987-03-30
PH19612A (en) 1986-05-27
NO841518L (no) 1984-10-19
IE57141B1 (en) 1992-05-06
GB2138290A (en) 1984-10-24
DD223063A5 (de) 1985-06-05
JPS59205313A (ja) 1984-11-20
US4595587A (en) 1986-06-17
CA1232202A (en) 1988-02-02
FI80590B (fi) 1990-03-30
DE3461054D1 (en) 1986-12-04
EP0122574B1 (de) 1986-10-29
NO164957B (no) 1990-08-27
CS247079B2 (en) 1986-11-13
PT78434B (de) 1986-08-22
IL71558A (en) 1987-10-30
IE840945L (en) 1984-10-18
HUT34350A (en) 1985-03-28
PL144291B1 (en) 1988-05-31
HK1690A (en) 1990-01-19
DE3314003A1 (de) 1984-10-18
PL247289A1 (en) 1985-07-16
DK161183B (da) 1991-06-10
KR840008281A (ko) 1984-12-14
NZ207876A (en) 1986-10-08
SU1356951A3 (ru) 1987-11-30
JPH0623096B2 (ja) 1994-03-30
DK119084A (da) 1984-10-19
IL71558A0 (en) 1984-07-31

Similar Documents

Publication Publication Date Title
FI841508A (fi) Delbar tablett med foerdroejd frigivning av aktivaemne och foerfarande foer dess framstaellning.
DE3168037D1 (en) Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient
NO905428D0 (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
NO904694D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
IT7830205A0 (it) Derivati di 1,3,4,5-tetraidrobenz-indolo erelativo procedimento per fabbricarli.
JPS56161371A (en) Sulfonamide derivative, its manufacture and its use as drug
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
NO811360L (no) Fremgangsmaate for fremstilling av terapeutisk aktivt hydratisert picotamid.
NO900972L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO175746C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.
FI842539A (fi) Foerfarande foer framstaellning av n2-arylsulfonyl-l-argininamider och farmaceutiskt acceptabla salter daerav.
NO871336D0 (no) Anvendelse av stoff som elektromagnetisk aktivt materiale.
NO891677D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater.
NO890506L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.
IT8025874A0 (it) Procedimento per la preparazione di isoftalonitrile.

Legal Events

Date Code Title Description
MA Patent expired

Owner name: BOEHRINGER INGELHEIM KG